Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | Profound Medical Corp. PROF | Flynn James E | 1,713,797 8.250% | 673,376 (+64.72%) | Filing History |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | Ignyte Acquisition Corp. IGNY | Flynn James E | 725,000 9.950% | 725,000 (New Position) | Filing History |
| 2022-02-11 4:12 pm Unchanged | 2021-12-31 | 13G | Orchard Therapeutics plc ORTX | Flynn James E | 694,942 5.540% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:12 pm Sale | 2021-12-31 | 13G | Apria, Inc. APR | Flynn James E | 1,655,795 4.670% | -775,622 (-31.90%) | Filing History |
| 2022-02-11 4:12 pm Purchase | 2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Flynn James E | 8,456,876 6.570% | 762,513 (+9.91%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Flynn James E | 958,125 3.470% | -1,594,662 (-62.47%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Flynn James E | 3,282,912 10.720% | -166,000 (-4.81%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Flynn James E | 29,204 0.030% | -9,500,796 (-99.69%) | Filing History |
| 2022-02-11 4:10 pm Sale | 2021-12-31 | 13G | IVERIC bio, Inc. ISEE | Flynn James E | 4,761,138 4.150% | -1,006,271 (-17.45%) | Filing History |
| 2022-02-11 4:10 pm Purchase | 2021-12-31 | 13G | Pulmonx Corporation LUNG | Flynn James E | 2,366,867 6.420% | 415,980 (+21.32%) | Filing History |
| 2022-02-11 4:10 pm Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Flynn James E | 5,580,456 9.540% | 1,376,556 (+32.74%) | Filing History |
| 2022-02-11 4:09 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Flynn James E | 10,000,000 8.060% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:09 pm Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Flynn James E | 1,175,131 4.800% | -630,906 (-34.93%) | Filing History |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | Flynn James E | 4,695,020 9.910% | 2,159,519 (+85.17%) | Filing History |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | AdaptHealth Corp. AHCO | Flynn James E | 24,272,428 7.720% | 2,871,653 (+13.42%) | Filing History |
| 2022-02-08 1:33 pm Sale | 2021-12-31 | 13G | Brookdale Senior Living Inc. BKD | Flynn James E | 4,274,808 2.310% | -6,748,657 (-61.22%) | Filing History |
| 2022-01-24 4:43 pm Purchase | 2022-01-13 | 13G | Silk Road Medical, Inc SILK | Flynn James E | 1,861,917 5.340% | 1,861,917 (New Position) | Filing History |
| 2021-12-07 5:19 pm Purchase | 2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR | Flynn James E | 10,000,000 8.170% | 10,000,000 (New Position) | Filing History |
| 2021-12-03 3:07 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | Flynn James E | 3,513,756 5.280% | 3,513,756 (New Position) | Filing History |
| 2021-11-19 5:19 pm Purchase | 2021-11-12 | 13D | DFP Healthcare Acquisitions Corp. DFPH | Flynn James E | 24,074,650 4.900% | 13,614,650 (+130.16%) | Filing History |